Figure 1.

MALAT1 was upregulated in cisplatin-resistant CC cells. (a) The expression of MALAT1 in CC patients and paracancerous cervical tissues. (b) The relative expression of MALAT1 in cisplatin-sensitive group and cisplatin-resistant group in CC patients. (c) Cell viability was assessed at varying concentrations of cisplatin to calculate IC₅₀ values. (d) The relative expression of MALAT1 in CC cell lines. (e) Kaplan-Meier analyzed the correlation between MALAT1 expression and overall survival rate in patients with CC from TCGA CC data sets. All the tests were carried out at least three times. ^∗∗P < 0.01, ^∗∗∗P < 0.001. All experiments were performed at least three times.